VEGFA and metabolic syndrome: Of note, in the case of subcutaneous tissue, metabolic syndrome led to a lower expression of VEGF (−33% and −40% for subObese (+) vs. subLean and subObese (+) vs. subObese (−), respectively; p < 0.05; Figure 3F).